7-[2-(乙基磺酰基)乙基]-6-羟基-1,3-二甲基-9-(苯基甲基)-嘧啶并[2,1-f]嘌呤-2,4,8(1H,3H,9H)-三酮结构式
|
常用名 | 7-[2-(乙基磺酰基)乙基]-6-羟基-1,3-二甲基-9-(苯基甲基)-嘧啶并[2,1-f]嘌呤-2,4,8(1H,3H,9H)-三酮 | 英文名 | Pyrimido[2,1-f]purine-2,4,8(1H,3H,9H)-trione,7-[2-(ethylsulfonyl)ethyl]-6-hydroxy-1,3-dimethyl-9-(phenylmethyl)- |
|---|---|---|---|---|
| CAS号 | 102212-69-1 | 分子量 | 473.50200 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C21H23N5O6S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | 7-[2-(乙基磺酰基)乙基]-6-羟基-1,3-二甲基-9-(苯基甲基)-嘧啶并[2,1-f]嘌呤-2,4,8(1H,3H,9H)-三酮 |
|---|---|
| 英文名 | 9-Benzyl-7-[2-(ethylsulfonyl)ethyl]-6-hydroxy-1,3-dimethylpyrimid o[2,1-f]purine-2,4,8(1H,3H,9H)-trione |
| 英文别名 | 更多 |
| 分子式 | C21H23N5O6S |
|---|---|
| 分子量 | 473.50200 |
| 精确质量 | 473.13700 |
| PSA | 146.05000 |
| LogP | 0.85850 |
|
~20%
7-[2-(乙基磺酰基)乙基]... 102212-69-1 |
| 文献:Blythin; Kaminski; Domalski; Spitler; Solomon; Conn; Wong; Verbiar; Bober; Chiu Journal of Medicinal Chemistry, 1986 , vol. 29, # 6 p. 1099 - 1113 |
|
~%
7-[2-(乙基磺酰基)乙基]... 102212-69-1 |
| 文献:Blythin; Kaminski; Domalski; Spitler; Solomon; Conn; Wong; Verbiar; Bober; Chiu Journal of Medicinal Chemistry, 1986 , vol. 29, # 6 p. 1099 - 1113 |
| 上游产品 2 | |
|---|---|
| 下游产品 0 | |
| 9-benzyl-1,17-dichloro-3,6,12,15-tetraoxa-9-azaheptadecane |
| Benzenemethanamine,N,N-bis[2-[2-(2-chloroethoxy)ethoxy]ethyl] |
| 9-benzyl-1,3-dimethyl-7-[2-(ethylsulfonyl)ethyl]-6-hydroxypyrimido[2,1-f]purine-2,4,8(1H,3H,9H)-trione |